Open an account

Cryoport

CYRX · NASDAQ

$17.44+$0.46 (+2.71%)TodayMarket closed ·
Prev close $16.98

About CYRX

CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. The company is headquartered in Brentwood, Tennessee and currently employs 684 full-time employees. The company went IPO on 2015-07-24. The firm operates through two segments: segments: Life Sciences Services and Life Sciences Products. Its life sciences services include BioLogistics and BioStorage/BioServices, which provides temperature-controlled logistics, biostorage and bioservices within the life science industry through direct sales. Its life sciences products segment manufactures and sells cryogenic systems, such as freezers and cryogenic dewars and related ancillary accessories used in the storage and transport of life science commodities through direct sales or a distribution network. Its operating units include Cryoport Systems, CryoGene and MVE Biological Solutions (MVE). Cryoport Systems provides temperature-controlled BioLogistics, BioServices, and cryopreservation solutions, supporting clinical and commercial workflows through transport, kit production, labeling, packaging, and others.

Employees
684
Headquarters
Brentwood, Tennessee
Listed
Jul 24, 2015
Sector
Health Care
Industry
Life Sciences Tools & Services
Website
cryoport.com

CYRX key statistics

Market cap
883.32M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
764.59K
Volume
1.09M
Open price
$16.91
High today
$17.51
Low today
$16.91
52 Week high
$18.36
52 Week low
$7.61

Cryoport (CYRX) at a glance

As of Oct 20, 2026, Cryoport (CYRX) shares are priced at $17.44, giving the company a market cap of 883.32M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $16.91 and $17.51. The current price is 3.1% above the day's low and 0.4% below its high.

Volume so far is 1.09M shares, above the average of 764.59K shares a day.

Over the past year Cryoport has ranged from $7.61 to $18.36, and now sits 91% of the way up that range.

Cryoport met or beat analyst EPS estimates in 4 of the last 8 quarters. In Q2 FY26 it reported -$0.20 per share against an estimate of -$0.1977.

The average analyst price target is $19.72, 13.1% above the current price, from 6 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 6 analyst ratings say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 11 analystsAvg $19.72
Low
$15.15
Now
$17.44
High
$26.25

CYRX earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 4 of the last 8 quarters, by 269.8% on average.

  1. Q3 FY24: reported -$0.02 per share against an estimate of -$0.2981
  2. Q4 FY24: reported -$0.42 per share against an estimate of -$0.2989
  3. Q1 FY25: reported -$0.28 per share against an estimate of -$0.3192
  4. Q2 FY25: reported $2.05 per share against an estimate of -$0.2391
  5. Q3 FY25: reported -$0.18 per share against an estimate of -$0.2153
  6. Q4 FY25: reported -$0.27 per share against an estimate of -$0.2097
  7. Q1 FY26: reported -$0.25 per share against an estimate of -$0.2208
  8. Q2 FY26: reported -$0.20 per share against an estimate of -$0.1977

CYRX news

  • Press releasePRNewswire

    Cryoport Reports Second Quarter 2026 Financial Results

  • Press releasePRNewswire

    Cryoport to Report Second Quarter 2026 Financial Results on August 6, 2026

  • Press releasePRNewswire

    Cryoport's IntegriCell® Cryopreservation Services Selected by Verismo Therapeutics to Support Clinical KIR-CAR T Cell Therapy Programs

  • Henry Khederian

    Cryoport Posts Revenue Beat In Q1 As Clinical Trial Support Hits All-Time High — 'A Strong Start To 2026'

  • Press releasePRNewswire

    Cryoport Reports First Quarter 2026 Financial Results

  • Press releasePRNewswire

    Cryoport to Report First Quarter 2026 Financial Results on May 4, 2026

  • Press releasePRNewswire

    Cryoport Reports Fourth Quarter and Full-Year 2025 Financial Results

  • Press releasePRNewswire

    Cryoport to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026

Similar companies

Companies in the same industry as Cryoport

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.